Collectively, gm-PBM markedly reversed fecal metabolic dysregulation in AD mice by bidirectionally correcting over 160 key metabolites involved in lipid, amino acid, and energy metabolism, and reactivating core metabolic pathways such as fatty acid biosynthesis and the PPAR/AMPK signaling axes. Here, PPARA is linked to Alzheimer disease.